IL1B and inflammatory bowel disease: Further studies have also highlighted that both pancreatitis and IBD share a common immune dysregulation and an altered cytokines expression, such as an abnormal elevation of IL-1β, IL-6, IL-8, and IL-10, thus supporting the susceptibility for IBD patients to develop pancreatic manifestations over time [42,43,44].